Examination of IgG Subclasses and CD32b Receptor Expression on Leukocytes Associated with Multi-Allergen Immunotherapy

被引：0
|
作者：
Patel, Pooja [1 ]
Tversky, Jody [2 ]
MacGlashan, Donald [3 ]
机构：
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
410
引用
收藏
页码：AB132 / AB132
页数：1
相关论文
共 9 条
  • [1] Targeting the inhibitory Fc gamma receptor CD32B to augment immunotherapy
    Roghanian, A.
    Teige, I.
    Manfredi, G.
    Shah, V.
    James, S.
    Smyth, N.
    Sheth, B.
    Chan, H. T. C.
    Tutt, A. L.
    Cox, K. L.
    Verbeek, J. S.
    Beers, S. A.
    Frendeus, B.
    Glennie, M. J.
    Cragg, M. S.
    IMMUNOLOGY, 2013, 140 : 19 - 19
  • [2] Expression profile of FcgammaRIIb (CD32B) on leukocytes and the dystregulation of FcgammaRIIb in systemic lupus erythematosus
    Su, Kaihong
    Yang, Hengxuan
    Li, Xinrui
    Gibson, Andrew W.
    Li, Xiaoli
    Zhou, Tong
    Cafardi, John M.
    Edberg, Jeffrey C.
    Kimberly, Robert P.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S155 - S156
  • [3] Immunotherapy Targeting Inhibitory Fcγ Receptor IIB (CD32b) in the Mouse Is Limited by Monoclonal Antibody Consumption and Receptor Internalization
    Williams, Emily L.
    Tutt, Alison L.
    Beers, Stephen A.
    French, Ruth R.
    Chan, Claude H. T.
    Cox, Kerry L.
    Roghanian, Ali
    Penfold, Christine A.
    Butts, Cherie L.
    Boross, Peter
    Verbeek, J. Sjef
    Cragg, Mark S.
    Glennie, Martin J.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (08): : 4130 - 4140
  • [4] Expression and modulation of the inhibitory Fcγ receptor, FcγRIIb (CD32b), on human dendritic cells (DCs)
    Boruchov, AM
    Young, JW
    BLOOD, 2003, 102 (11) : 522A - 522A
  • [5] Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells
    Hullsiek, Robert
    Li, Yunfang
    Snyder, Kristin M.
    Wang, Sam
    Di, Da
    Borgatti, Antonella
    Lee, Chae
    Moore, Peter F.
    Zhu, Cong
    Fattori, Chiara
    Modiano, Jaime F.
    Wu, Jianming
    Walcheck, Bruce
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] An Fc-optimized monoclonal antibody against CD32B, the human inhibitory Fc-γreceptor IIB, in the immunotherapy of B-cell malignanacy.
    Stavenhagen, Jeffrey B.
    Gorlatov, Sergey
    Tuaillon, Nadine
    Rankin, Christopher T.
    Veri, Maria-Concetta
    Inzunza, David
    Burke, Stephen
    Huang, Ling
    Li, Hua
    Thomas, Shannon
    Johnson, Syd
    Ravetch, Jeffrey
    Koenig, Scott
    Bonvini, Ezio
    BLOOD, 2006, 108 (11) : 715A - 715A
  • [7] The functional variant of the inhibitory Fcγ receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis
    Radstake, Timothy R. D. J.
    Franke, Barbara
    Wenink, Mark H.
    Nabbe, Karin C. A. A.
    Coenen, Marieke J. H.
    Welsing, Paco
    Bonvini, Ezio
    Koenig, Scott
    van den Berg, Wim B.
    Barrera, Pilar
    van Riel, Piet L. C. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 3828 - 3837
  • [8] Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
    Lee, Chern Siang
    Ashton-Key, Margaret
    Cogliatti, Sergio
    Rondeau, Stephanie
    Schmitz, Shu-Fang Hsu
    Ghielmini, Michele
    Cragg, Mark S.
    Johnson, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 145 - 148
  • [9] Selective Expression of Latency Associated Peptide (LAP) and IL-1 Receptor Type I/II (CD121a/CD121b) on Activated Human FOXP3+Regulatory T Cells Allows for Their Purification from Expansion Cultures for Potential Immunotherapy
    Tran, Dat
    Shevach, Ethan
    CLINICAL IMMUNOLOGY, 2009, 131 : S81 - S82
1